This Article Full Text (PDF) All Versions of this Article: 106/15/1943    most recent 01.CIR.0000034044.95911.DCv1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sudhop, T. Articles by von Bergmann, K. Search for Related Content PubMed PubMed Citation Articles by Sudhop, T. Articles by von Bergmann, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Related Collections Lipids Other Treatment Lipid and lipoprotein metabolism

This article has been cited by other articles:

				M. E. Greenberg, J. D. Smith, and E. Sehayek Moderately Decreased Cholesterol Absorption Rates Are Associated With a Large Atheroprotective Effect Arterioscler Thromb Vasc Biol, November 1, 2009; 29(11): 1745 - 1750. [Abstract] [Full Text] [PDF]

				T. Sudhop, M. Reber, D. Tribble, A. Sapre, W. Taggart, P. Gibbons, T. Musliner, K. von Bergmann, and D. Lutjohann Changes in cholesterol absorption and cholesterol synthesis caused by ezetimibe and/or simvastatin in men J. Lipid Res., October 1, 2009; 50(10): 2117 - 2123. [Abstract] [Full Text] [PDF]

				A. J Tremblay, B. Lamarche, J.-C. Hogue, and P. Couture Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia J. Lipid Res., July 1, 2009; 50(7): 1463 - 1471. [Abstract] [Full Text] [PDF]

				A. Meaney, G. Ceballos, J. Asbun, G. Solache, E. Mendoza, A. Vela, and E. Meaney The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study J. Clin. Pharmacol., July 1, 2009; 49(7): 838 - 847. [Abstract] [Full Text] [PDF]

				T. M. van Himbergen, N. R. Matthan, N. A. Resteghini, S. Otokozawa, M. Ai, E. A. Stein, P. H. Jones, and E. J. Schaefer Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers J. Lipid Res., April 1, 2009; 50(4): 730 - 739. [Abstract] [Full Text] [PDF]

				F. J. Al Badarin, I. J. Kullo, S. L. Kopecky, and R. J. Thomas Impact of Ezetimibe on Atherosclerosis: Is the Jury Still Out? Mayo Clin. Proc., April 1, 2009; 84(4): 353 - 361. [Abstract] [Full Text] [PDF]

				G. Silbernagel, G. Fauler, W. Renner, E. M. Landl, M. M. Hoffmann, B. R. Winkelmann, B. O. Boehm, and W. Marz The relationships of cholesterol metabolism and plasma plant sterols with the severity of coronary artery disease J. Lipid Res., February 1, 2009; 50(2): 334 - 341. [Abstract] [Full Text] [PDF]

				P.-Y. Liu, Y.-W. Liu, L.-J. Lin, J.-H. Chen, and J. K. Liao Evidence for Statin Pleiotropy in Humans: Differential Effects of Statins and Ezetimibe on Rho-Associated Coiled-Coil Containing Protein Kinase Activity, Endothelial Function, and Inflammation Circulation, January 6, 2009; 119(1): 131 - 138. [Abstract] [Full Text] [PDF]

				E. D. Labonte, L. M. Camarota, J. C. Rojas, R. J. Jandacek, D. E. Gilham, J. P. Davies, Y. A. Ioannou, P. Tso, D. Y. Hui, and P. N. Howles Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G776 - G783. [Abstract] [Full Text] [PDF]

				M. A. Valasek, J. J. Repa, G. Quan, J. M. Dietschy, and S. D. Turley Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters Am J Physiol Gastrointest Liver Physiol, October 1, 2008; 295(4): G813 - G822. [Abstract] [Full Text] [PDF]

				S. Helske, T. Miettinen, H. Gylling, M. Mayranpaa, J. Lommi, H. Turto, K. Werkkala, M. Kupari, and P. T. Kovanen Accumulation of cholesterol precursors and plant sterols in human stenotic aortic valves J. Lipid Res., July 1, 2008; 49(7): 1511 - 1518. [Abstract] [Full Text] [PDF]

				O. Weingartner, D. Lutjohann, S. Ji, N. Weisshoff, F. List, T. Sudhop, K. von Bergmann, K. Gertz, J. Konig, H.-J. Schafers, et al. Vascular effects of diet supplementation with plant sterols. J. Am. Coll. Cardiol., April 22, 2008; 51(16): 1553 - 1561. [Abstract] [Full Text] [PDF]

				A. Tavridou, L. Kaklamanis, A. Papalois, A. P. Kourounakis, E. A. Rekka, P. N. Kourounakis, A. Charalambous, and V. G. Manolopoulos EP2306 [2-(4-Biphenyl)-4-methyl-octahydro-1,4-benzoxazin-2-ol, hydrobromide], A Novel Squalene Synthase Inhibitor, Reduces Atherosclerosis in the Cholesterol-Fed Rabbit J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 794 - 804. [Abstract] [Full Text] [PDF]

				J. S Sampalis, S. Bissonnette, R. Habib, S. Boukas, and for the Ezetrol Add-On Investigators Reduction in Estimated Risk for Coronary Artery Disease After Use of Ezetimibe with a Statin Ann. Pharmacother., September 1, 2007; 41(9): 1345 - 1351. [Abstract] [Full Text] [PDF]

				M. Piorkowski, S. Fischer, C. Stellbaum, M. Jaster, P. Martus, A. J. Morguet, H.-P. Schultheiss, and U. Rauch Treatment With Ezetimibe Plus Low-Dose Atorvastatin Compared With Higher-Dose Atorvastatin Alone: Is Sufficient Cholesterol-Lowering Enough to Inhibit Platelets? J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1035 - 1042. [Abstract] [Full Text] [PDF]

				J. J. Clarenbach, M. Reber, D. Lutjohann, K. von Bergmann, and T. Sudhop The lipid-lowering effect of ezetimibe in pure vegetarians J. Lipid Res., December 1, 2006; 47(12): 2820 - 2824. [Abstract] [Full Text] [PDF]

				E. J. Westover, X. Lin, T. E. Riehl, L. Ma, W. F. Stenson, D. F. Covey, and R. E. Ostlund Jr. Rapid transient absorption and biliary secretion of enantiomeric cholesterol in hamsters J. Lipid Res., November 1, 2006; 47(11): 2374 - 2381. [Abstract] [Full Text] [PDF]

				L. K Nies, A. A Cymbala, S. L Kasten, D. G Lamprecht, and K. L Olson Complementary and Alternative Therapies for the Management of Dyslipidemia Ann. Pharmacother., November 1, 2006; 40(11): 1984 - 1992. [Abstract] [Full Text] [PDF]

				M. Denke, T. Pearson, P. McBride, R. A Gazzara, W. E Brady, and A. M Tershakovec Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome Diabetes and Vascular Disease Research, September 1, 2006; 3(2): 93 - 102. [Abstract] [PDF]

				A. J. Tremblay, B. Lamarche, J. S. Cohn, J.-C. Hogue, and P. Couture Effect of Ezetimibe on the In Vivo Kinetics of ApoB-48 and ApoB-100 in Men With Primary Hypercholesterolemia Arterioscler Thromb Vasc Biol, May 1, 2006; 26(5): 1101 - 1106. [Abstract] [Full Text] [PDF]

				R. P. Radermecker and A. J. Scheen Serum Plant Sterols and Atherosclerosis: Is There a Place for Statin-Ezetimibe Combination? J. Am. Coll. Cardiol., April 4, 2006; 47(7): 1496 - 1497. [Full Text] [PDF]

				L. Yu, S. Bharadwaj, J. M. Brown, Y. Ma, W. Du, M. A. Davis, P. Michaely, P. Liu, M. C. Willingham, and L. L. Rudel Cholesterol-regulated Translocation of NPC1L1 to the Cell Surface Facilitates Free Cholesterol Uptake J. Biol. Chem., March 10, 2006; 281(10): 6616 - 6624. [Abstract] [Full Text] [PDF]

				L. Jakulj, M. D. Trip, T. Sudhop, K. von Bergmann, J. J. P. Kastelein, and M. N. Vissers Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe: effects on plasma lipid levels J. Lipid Res., December 1, 2005; 46(12): 2692 - 2698. [Abstract] [Full Text] [PDF]

				A. During, H. D. Dawson, and E. H. Harrison Carotenoid Transport Is Decreased and Expression of the Lipid Transporters SR-BI, NPC1L1, and ABCA1 Is Downregulated in Caco-2 Cells Treated with Ezetimibe J. Nutr., October 1, 2005; 135(10): 2305 - 2312. [Abstract] [Full Text] [PDF]

				G D Kolovou, K K Anagnostopoulou, and D V Cokkinos Pathophysiology of dyslipidaemia in the metabolic syndrome Postgrad. Med. J., June 1, 2005; 81(956): 358 - 366. [Abstract] [Full Text] [PDF]

				A. F.H. Stalenhoef Management of mixed hyperlipidaemia Eur. Heart J., May 1, 2005; 26(9): 856 - 857. [Full Text] [PDF]

				T. A. Pearson, M. A. Denke, P. E. McBride, W. P. Battisti, W. E. Brady, and J. Palmisano A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial Mayo Clin. Proc., May 1, 2005; 80(5): 587 - 595. [Abstract] [PDF]

				J. J. Repa, S. D. Turley, G. Quan, and J. M. Dietschy Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption J. Lipid Res., April 1, 2005; 46(4): 779 - 789. [Abstract] [Full Text] [PDF]

				K. A. Spratt and M. A. Denke Utility of Currently Available Modes of Therapy in Reaching Lipid Goals J Am Osteopath Assoc, September 1, 2004; 104(9_suppl): 14S - 16S. [Abstract] [Full Text] [PDF]

				C. J. Vaughan and A. M. Gotto Jr Update on Statins: 2003 Circulation, August 17, 2004; 110(7): 886 - 892. [Full Text] [PDF]

				H. R. Davis Jr., L.-j. Zhu, L. M. Hoos, G. Tetzloff, M. Maguire, J. Liu, X. Yao, S. P. N. Iyer, M.-H. Lam, E. G. Lund, et al. Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis J. Biol. Chem., August 6, 2004; 279(32): 33586 - 33592. [Abstract] [Full Text] [PDF]

				G. Salen, K. von Bergmann, D. Lutjohann, P. Kwiterovich, J. Kane, S.B. Patel, T. Musliner, P. Stein, B. Musser, and the Multicenter Sitosterolemia Study Group Ezetimibe Effectively Reduces Plasma Plant Sterols in Patients With Sitosterolemia Circulation, March 2, 2004; 109(8): 966 - 971. [Abstract] [Full Text] [PDF]

				E. Sehayek Genetic regulation of cholesterol absorption and plasma plant sterol levels: commonalities and differences J. Lipid Res., November 1, 2003; 44(11): 2030 - 2038. [Abstract] [Full Text] [PDF]

				L. Berglund and D. Hyson Cholesterol Absorption and the Metabolic Syndrome: A New Look at an Old Area Arterioscler Thromb Vasc Biol, August 1, 2003; 23(8): 1314 - 1316. [Full Text] [PDF]

				P. O. Kwiterovich Jr., S. C. Chen, D. G. Virgil, A. Schweitzer, D. R. Arnold, and L. E. Kratz Response of obligate heterozygotes for phytosterolemia to a low-fat diet and to a plant sterol ester dietary challenge J. Lipid Res., June 1, 2003; 44(6): 1143 - 1155. [Abstract] [Full Text] [PDF]

				V. F Mauro and C. E Tuckerman Ezetimibe for Management of Hypercholesterolemia Ann. Pharmacother., June 1, 2003; 37(6): 839 - 848. [Abstract] [Full Text] [PDF]

				M. van Heek and H. Davis Pharmacology of ezetimibe Eur. Heart J. Suppl., December 1, 2002; 4(suppl_J): J5 - J8. [Abstract] [PDF]

				C.M. Ballantyne Ezetimibe: efficacy and safety in clinical trials Eur. Heart J. Suppl., December 1, 2002; 4(suppl_J): J9 - J18. [Abstract] [PDF]